---
title: "vigabatrin - West syndrome"
sidebar: mydoc_sidebar
permalink: vigabatrinwestsyndrome.html
toc: false 
---

{% include image.html url="vigabatrinwestsyndrome.png" file="vigabatrinwestsyndrome.png" alt="vigabatrinwestsyndrome" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D020888 | vigabatrin | Drug |
| UniProt:P80404 | GABA transaminase (GABA-T) | Protein |
| MESH:C009338 | succinic semialdehyde | ChemicalSubstance |
| MESH:D005680 | GABA | ChemicalSubstance |
| UBERON:0001017 | central nervous system | GrossAnatomicalStructure |
| MESH:D013036 | West syndrome | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Vigabatrin | DECREASES ACTIVITY OF | Gaba Transaminase (Gaba-T) |
| Gaba Transaminase (Gaba-T) | DECREASES ABUNDANCE OF | Succinic Semialdehyde |
| Succinic Semialdehyde | INCREASES ABUNDANCE OF | Gaba |
| Gaba | LOCATED IN | Central Nervous System |
| Central Nervous System | TREATS | West Syndrome |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB01080#mechanism-of-action](https://go.drugbank.com/drugs/DB01080#mechanism-of-action){:target="_blank"}